Immunohistochemical localization of metallothionein in human prostate cancer

Journal of Urology

Volumn 156, Issue 5, 1996, Pages 1679-1681

  Zhang, Xiang Hua ^a   Jin, Li ^a   Sakamoto, Haruhiko ^a   Takenaka, Ikumasa ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

immunohistochemistry; metallothionein; prostatic neoplasms

Indexed keywords

METALLOTHIONEIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

EID: 0029903419     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)65481-8     Document Type: Article

References (16)

1. Mayo, K. E. and Palmiter, R. D.: Glucocorticoid regulation of metallothionein-I mRNA in cultured mouse cells. J. Biol. Chem., 256: 2621, 1981.
2. Cousins, R. J. and Leinart, A. S.: Tissue-specific regulation of zinc metabolism and metallothionein genes by interleukin 1. FASEB J., 2: 2884, 1988.
3. Hamer, D. H.: Metallothionein. Ann. Rev. Biochem., 55: 913, 1986.
4. Suzuki, T., Umeyama, T., Ohma, C., Yamanaka, H., Suzuki, K., Nakajima, K. and Kimura, M.: Immunohistochemical study of metallothionein in normal and benign prostatic hyperplasia of human prostate. Prostate, 19: 35, 1991.
5. Nishimura, H., Nishimura, N. and Tohyama, C.: Localization of metallothionein in the genital organs of the male rat. J. Histochem. Cytochem., 38: 927, 1990.
6. Gleason, D. F.: Histologic grading and clinical staging of prostatic carcinoma. In: Urologic Pathology: The Prostate. Edited by M. Tannenbaum. Philadelphia: Lea & Febiger, chapt. 9, pp. 171-198, 1977.
7. Petersen, R. O.: Neoplastic disorders. In: Urologic Pathology. Philadelphia: J. B. Lippincott Co., pp. 613-668, 1986.
8. Kontozoglou, T. E., Banerjee, D. and Cherian, G.: Immunohistochemical localization of metallothionein in human testicular embryonal carcinoma cells. Virchows Arch. A Path. Anat. Histopath., 415: 545, 1989.
9. Nartey, N., Cherian, M. J. and Banerjee, D.: Immunohistochemical localization of metallothionein in human thyroid tumors. Amer. J. Path., 129: 177, 1987.
10. Fresno, M., Wu, W., Rodriguez, J. M. and Nadji, M.: Localization of metallothionein in breast carcinomas. An immunohistochemical study. Virchows Arch. A Path. Anat. Histopath., 423: 215, 1993.
11. Schmid, K. W., Ellis, I. O., Gee, J. M., Darke, B. M., Lees, W. E., Kay, J., Cryer, A., Stark, J. M., Hittmair, A., Ofner, D., Dunser, M., Bocker, W. and Jasani, B.: Presence and possible significance of immunocytochemically demonstrable metallothionein over-expression in primary invasive ductal carcinoma of the breast. Virchows Arch. A Path. Anat. Histopath., 422: 153, 1993.
12. Bahnson, R. R., Banner, B. F., Ernstoff, M. S., Lazo, J. S., Cherian, M. G., Banerjee, D. and Chin, J. L.: Immunohistochemical localization of metallothionein in transitional cell carcinoma of the bladder. J. Urol., 146: 1518, 1991.
13. Kotoh, S., Naito, S., Sakamoto, N., Goto, K. and Kumazawa, J.: Metallothionein expression is correlated with cisplatin resistance in transitional cell carcinoma of the urinary tract. J. Urol., 152: 1267, 1994.
14. Feustel, A., Wennrich, R., Steiniger, D. and Klauss, P.: Zinc and cadmium concentration in prostatic carcinoma of different histological grading in comparison to normal prostate tissue and adenofibromyomatosis (BPH). Urol. Res., 10: 301, 1982.
15. Ogunlewe, J. O. and Osegbe, D. N.: Zinc and cadmium concentrations in indigenous blacks with normal, hypertrophic, and malignant prostate. Cancer, 63: 1388, 1989.
16. Thind, G. S. and Fischer, G. M.: Plasma cadmium and zinc in human hypertension. Clin. Sci. Molec. Med., 51: 483, 1976.